Demetri George

Director at Blueprint Medicines Corp · on record since Apr 30, 2015
Director at MERRIMACK PHARMACEUTICALS INC · on record since Dec 15, 2017
Director at Translate Bio, Inc. · on record since Jul 15, 2019

Insider trading activity of Demetri George

Transactions on record: 40; since Jun 27, 2016

Open-market buys: 1; $826.6

Open-market sells: 15; $1.7M

Companies traded: 3; last filing Jun 30, 2022

Figures computed from official regulatory filings — .

Companies where Demetri George has traded

Blueprint Medicines Corp29 tx · $1.7M · Jun 30, 2022
Translate Bio, Inc.9 tx · Sep 14, 2021
MERRIMACK PHARMACEUTICALS INC2 tx · Jun 15, 2018

Track record of Demetri George

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Demetri George

Co-insiders of Demetri George

Beckman DaniellaBlueprint Medicines Corp +1
LYNCH DANIELBlueprint Medicines Corp +1
Albers Jeffrey W.Blueprint Medicines Corp
Al-Wakeel Yasir B.MERRIMACK PHARMACEUTICALS INC
Andersen EricMERRIMACK PHARMACEUTICALS INC
Atlas Venture Associates VIII, L.P.Translate Bio, Inc.
Barbier AnnTranslate Bio, Inc.
Boral Anthony L.Blueprint Medicines Corp
Borisy AlexisBlueprint Medicines Corp
Burgess Paul D.Translate Bio, Inc.
Carter Percy H.Blueprint Medicines Corp
Cloghessy PaulaTranslate Bio, Inc.
COATS LONNELBlueprint Medicines Corp
CROCKER GARY LMERRIMACK PHARMACEUTICALS INC
Dable Habib JBlueprint Medicines Corp
Dineen John M.MERRIMACK PHARMACEUTICALS INC
Dorsch MarionBlueprint Medicines Corp
Dresser James van B.MERRIMACK PHARMACEUTICALS INC
Drummond Daryl CMERRIMACK PHARMACEUTICALS INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Blueprint Medicines CorpListing unverified	Jun 30, 2022	Buy	10	82.66 USD	$826.6	conv 30First in 12mo	SEC
Blueprint Medicines CorpListing unverified	Jun 30, 2022	Sell	-10	58.56 USD	$585.6		SEC
Blueprint Medicines CorpListing unverified	Jun 30, 2022	AwardD (derivative)	5,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 30, 2022	Award	2,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-37,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-37,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-18,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-18,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Jun 16, 2021	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 4, 2021	Award	2,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 4, 2021	AwardD (derivative)	4,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jan 6, 2021	Sell	-758	112.15 USD	$85K		SEC
Blueprint Medicines CorpListing unverified	Sep 24, 2020	Sell	-1,704	85.00 USD	$144.8K		SEC
Blueprint Medicines CorpListing unverified	Jun 26, 2020	Award	2,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 26, 2020	AwardD (derivative)	4,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 23, 2020	Exercise	1,312	—	n/a (No price was disclosed in the filing)		SEC
Blueprint Medicines CorpListing unverified	Jun 23, 2020	ExerciseD (derivative)	-1,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Jun 16, 2020	AwardD (derivative)	18,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jan 14, 2020	Sell	-568	85.00 USD	$48.3K		SEC
Blueprint Medicines CorpListing unverified	Jan 9, 2020	Sell	-1,705	80.59 USD	$137.4K		SEC
Translate Bio, Inc.Listing unverified	Jul 15, 2019	AwardD (derivative)	37,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 20, 2019	AwardD (derivative)	1,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 20, 2019	AwardD (derivative)	4,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Blueprint Medicines CorpListing unverified	Jun 30, 2022	Buy	10	82.66 USD	$826.6	conv 30First in 12mo	SEC
Blueprint Medicines CorpListing unverified	Jun 30, 2022	Sell	-10	58.56 USD	$585.6		SEC
Blueprint Medicines CorpListing unverified	Jun 30, 2022	AwardD (derivative)	5,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 30, 2022	Award	2,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-37,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-37,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-18,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Sep 14, 2021	SellD (derivative)	-18,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Jun 16, 2021	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 4, 2021	Award	2,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 4, 2021	AwardD (derivative)	4,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jan 6, 2021	Sell	-758	112.15 USD	$85K		SEC
Blueprint Medicines CorpListing unverified	Sep 24, 2020	Sell	-1,704	85.00 USD	$144.8K		SEC
Blueprint Medicines CorpListing unverified	Jun 26, 2020	Award	2,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 26, 2020	AwardD (derivative)	4,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 23, 2020	Exercise	1,312	—	n/a (No price was disclosed in the filing)		SEC
Blueprint Medicines CorpListing unverified	Jun 23, 2020	ExerciseD (derivative)	-1,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Translate Bio, Inc.Listing unverified	Jun 16, 2020	AwardD (derivative)	18,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jan 14, 2020	Sell	-568	85.00 USD	$48.3K		SEC
Blueprint Medicines CorpListing unverified	Jan 9, 2020	Sell	-1,705	80.59 USD	$137.4K		SEC
Translate Bio, Inc.Listing unverified	Jul 15, 2019	AwardD (derivative)	37,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 20, 2019	AwardD (derivative)	1,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Blueprint Medicines CorpListing unverified	Jun 20, 2019	AwardD (derivative)	4,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC